NON VALVULAR ATRIAL FIBRILLATION
Clinical trials for NON VALVULAR ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new NON VALVULAR ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for NON VALVULAR ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart implant offers Blood-Thinner alternative for stroke prevention
Disease control OngoingThis early study is testing a small heart implant called the Laminar Left Atrial Appendage Closure System. It's designed for people with atrial fibrillation who cannot take long-term blood thinners but still need stroke prevention. The device is placed in the heart to seal off an…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Heart implant trial aims to block stroke risk without lifelong blood thinners
Disease control TerminatedThis study is testing a new heart implant device designed to seal off a small pouch in the heart where blood clots often form in people with atrial fibrillation. The goal is to prevent strokes and other blood clots without requiring patients to take lifelong blood-thinning medica…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Tiny heart plug aims to stop killer strokes
Disease control OngoingThis early study is testing a new heart implant called the CLAAS device. It is designed for people with atrial fibrillation (AFib) who are at high risk of stroke but cannot take long-term blood thinners. The device is placed to seal off a small pouch in the heart where dangerous …
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Conformal Medical, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New heart plug aims to stop strokes without blood thinners
Disease control OngoingThis study is testing a small, permanent heart implant called the Omega™ LAA Occluder. It is designed for people with a common heart rhythm problem (atrial fibrillation) who are at high risk for strokes but also have a high risk of dangerous bleeding, which prevents them from saf…
Matched conditions: NON VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC